Differences in second trimester risk estimates for trisomy 21 between Maglumi X3/Preaccu and Immulite/Prisca systems
Maternal serum alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) or free β-HCG, and unconjugated estriol (uE3) concentrations are used to screen trisomy 21 in the second trimester. The performance of different analytical platforms has an impact on individual risk estimates. The aim of this...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2024-12-01
|
| Series: | Türk Biyokimya Dergisi |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/tjb-2023-0203 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850041913335349248 |
|---|---|
| author | Üstündağ Yasemin Huysal Kağan Yeşil Meryem Rümeysa |
| author_facet | Üstündağ Yasemin Huysal Kağan Yeşil Meryem Rümeysa |
| author_sort | Üstündağ Yasemin |
| collection | DOAJ |
| description | Maternal serum alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) or free β-HCG, and unconjugated estriol (uE3) concentrations are used to screen trisomy 21 in the second trimester. The performance of different analytical platforms has an impact on individual risk estimates. The aim of this study is to compare the multiple of median (MoM) values and risk estimates generated by Maglumi X3 analyzer/Preaccu software with the Immulite 2000 XPi device/Prisca software. |
| format | Article |
| id | doaj-art-508bab222a7d4c45a8627d29b7779da3 |
| institution | DOAJ |
| issn | 1303-829X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | De Gruyter |
| record_format | Article |
| series | Türk Biyokimya Dergisi |
| spelling | doaj-art-508bab222a7d4c45a8627d29b7779da32025-08-20T02:55:40ZengDe GruyterTürk Biyokimya Dergisi1303-829X2024-12-01501465110.1515/tjb-2023-0203Differences in second trimester risk estimates for trisomy 21 between Maglumi X3/Preaccu and Immulite/Prisca systemsÜstündağ Yasemin0Huysal Kağan1Yeşil Meryem Rümeysa2Department of Biochemistry, University of Health Sciences Bursa Yuksek Ihtisas Research and Training Hospital, Bursa, TürkiyeDepartment of Biochemistry, University of Health Sciences Bursa Yuksek Ihtisas Research and Training Hospital, Bursa, TürkiyeDepartment of Biochemistry, University of Health Sciences Bursa Yuksek Ihtisas Research and Training Hospital, Bursa, TürkiyeMaternal serum alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) or free β-HCG, and unconjugated estriol (uE3) concentrations are used to screen trisomy 21 in the second trimester. The performance of different analytical platforms has an impact on individual risk estimates. The aim of this study is to compare the multiple of median (MoM) values and risk estimates generated by Maglumi X3 analyzer/Preaccu software with the Immulite 2000 XPi device/Prisca software.https://doi.org/10.1515/tjb-2023-0203method comparisonmaglumi x3/preaccu systemsecond trimester down screeningrisk assessmentimmulite/prisca system |
| spellingShingle | Üstündağ Yasemin Huysal Kağan Yeşil Meryem Rümeysa Differences in second trimester risk estimates for trisomy 21 between Maglumi X3/Preaccu and Immulite/Prisca systems Türk Biyokimya Dergisi method comparison maglumi x3/preaccu system second trimester down screening risk assessment immulite/prisca system |
| title | Differences in second trimester risk estimates for trisomy 21 between Maglumi X3/Preaccu and Immulite/Prisca systems |
| title_full | Differences in second trimester risk estimates for trisomy 21 between Maglumi X3/Preaccu and Immulite/Prisca systems |
| title_fullStr | Differences in second trimester risk estimates for trisomy 21 between Maglumi X3/Preaccu and Immulite/Prisca systems |
| title_full_unstemmed | Differences in second trimester risk estimates for trisomy 21 between Maglumi X3/Preaccu and Immulite/Prisca systems |
| title_short | Differences in second trimester risk estimates for trisomy 21 between Maglumi X3/Preaccu and Immulite/Prisca systems |
| title_sort | differences in second trimester risk estimates for trisomy 21 between maglumi x3 preaccu and immulite prisca systems |
| topic | method comparison maglumi x3/preaccu system second trimester down screening risk assessment immulite/prisca system |
| url | https://doi.org/10.1515/tjb-2023-0203 |
| work_keys_str_mv | AT ustundagyasemin differencesinsecondtrimesterriskestimatesfortrisomy21betweenmaglumix3preaccuandimmulitepriscasystems AT huysalkagan differencesinsecondtrimesterriskestimatesfortrisomy21betweenmaglumix3preaccuandimmulitepriscasystems AT yesilmeryemrumeysa differencesinsecondtrimesterriskestimatesfortrisomy21betweenmaglumix3preaccuandimmulitepriscasystems |